Expand FDMT Menu
FDMT MENU

4D Molecular Therapeutics (FDMT) closed at $10.23 on November 20, 2026, down 4.6% from the previous close, on volume of 648,195 shares (30-day average 905,208).

Key numbers
  • Last close: $10.23 (November 20, 2026)
  • 52-week range: $6.96 to $16.93
  • Market value: $576.8 million
  • 30-day implied volatility (IV30): 84.4%
  • Option volume: 1 contracts (1 calls, 0 puts); 30-day average 136

Data as of November 20, 2026.

FDMT Stock Summary and Trading Ideas (4D Molecular Therapeutics | NASDAQ:FDMT)

Charts for Today's Stock Price and Implied Volatility in 4D Molecular Therapeutics

20-Nov-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for FDMT by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts
1 Nov 13, 2026 Put with Delta Hedge 15-Jan-27 12 P +40,000 Stock 1,000
2-3 The next 2 largest trades are for Premium members. Start a 7-day free trial

Premium Feature

Login|Subscribe

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 20, 2026. See the largest for 5, 30, 60 and 90 days

Trading Statistics

Key Ratios

4D Molecular Therapeutics (FDMT) Frequently Asked Questions

What does 4D Molecular Therapeutics do?

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

What symbol and exchange does 4D Molecular Therapeutics shares trade?

4D Molecular Therapeutics trades on the NASDAQ stock market under the symbol FDMT.

What is 4D Molecular Therapeutics stock price doing today?

As of November 20, 2026, FDMT stock price declined to $10.23 with 648,195 million shares trading.

What is 4D Molecular Therapeutics's Beta?

FDMT has a beta of 1.21, meaning it tends to be more sensitive to market movements. FDMT has a correlation of 0.07 to the broad based SPY ETF.

How much is 4D Molecular Therapeutics worth?

FDMT has a market cap of $576.76 million. This is considered a Small Cap stock.

How much money does 4D Molecular Therapeutics make?

Last quarter 4D Molecular Therapeutics reported $4 million in Revenue and -$1.08 earnings per share. This beat revenue expectation by $923,904 and missed earnings estimates by -$.03.

What is the highest and lowest price 4D Molecular Therapeutics traded in the last 3 year period?

In the last 3 years, FDMT traded as high as $36.25 and as low as $2.24.

What are the top ETFs holding 4D Molecular Therapeutics?

The top ETF exchange traded funds that FDMT belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWN.

Is 4D Molecular Therapeutics (FDMT) a good investment?

FDMT has underperformed the market in the last year with a price return of -1.1% while the SPY ETF gained +6.9%. FDMT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -36.5% and -16.5%, respectively, while the SPY returned -9.3% and -6.2%, respectively.

What are the support and resistance levels for 4D Molecular Therapeutics (FDMT)?

FDMT support price is $10.08 and resistance is $11.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FDMT shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes